Towards Healthcare
Theranostics Market Expand at 15.46% CAGR till 2034

Theranostics Market Size 2025 to 2034 Radiopharmaceuticals & AI Integration to Fuel 15.46% CAGR

According to market projections, the theranostics sector is expected to grow from USD 2.42 billion in 2024 to USD 10.21 billion by 2034, reflecting a CAGR of 15.46%. Technological advancements and boosting non-oncological applications are driving the global market expansion. North America led with its rising cancer cases and healthcare system.

Content

  • Last Updated: 19 August 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The theranostics market is valued at USD 2.8 billion in 2025 and is on track to reach USD 10.21 billion by 2034, witnessing a steady CAGR of 15.46% during the forecast span.

North America is currently leading the theranostics market due to the increasing incidence of different cancers and a strong healthcare infrastructure.

The theranostics market includes 5 segments such as by product type, by technology, by application, by end user, and by region.

Key trends include accelerating demand for precision medicine and targeted therapies, growth in the R&D investments, and innovation in diagnostic imaging technologies and radiopharmaceuticals.

It allows the visualisation of the cellular function and the follow up of the molecular process in living organisms with out perturbing them.

The popular diagnostic imaging techniques include MRI, CT scans, X-rays, ultrasound, and nuclear medicine imaging.

AERB, US FDA, CDC, NIH, MedlinePlus.gov, NIDC, Clinicaltrials.gov
Any Questions